Korea Stocks, page 4 of 36 — 24 articles published 2026-09-14 ~ 2026-09-17.
Byucksan (KRX 007210) stock outlook 2026 for foreign investors: mineral wool insulation, gypsum board and ceiling tile business, non-combustible material regulation upside, Korean housing-cycle sensitivity, raw-material FX exposure, peer comparison, and home-country tax mechanics for holding a Korean small-cap directly.
Namuga (KRX: 190510) stock outlook for 2026, covering its smartphone camera module base business, ToF and structured-light 3D sensing, automotive and robot vision expansion, ties to Dreamtech, set-maker dependency, and what foreign investors should know about Korean-listed small caps.
Amogreentech (KOSDAQ: 125210) stock outlook for 2026 — the Amotech-affiliated materials maker behind thermal sheets, nanofiber membranes, and magnetic EMI shielding. Covers EV and ESS exposure, affiliate governance risk, and why quarterly earnings swing so hard.
YC (formerly YIK, KOSDAQ 232140) stock outlook for 2026. A look at its wafer burn-in test equipment business, the strength and fragility of its near-captive relationship with Samsung Electronics, HBM/DRAM cycle leverage, customer concentration risk, and the metrics worth tracking each quarter.
Hironic (KOSDAQ 149980) stock outlook 2026: how the HIFU and RF aesthetic device maker balances one-time equipment sales against recurring cartridge consumable revenue, how it stacks up against Classys, Jeisys Medical and Wontech, and what won exposure means for exports.
Englewood Lab (950140) stock outlook 2026 for foreign investors: the New Jersey-based skincare ODM's US-Korea structure, customer concentration risk, dollar-revenue-versus-import-cost currency mechanics, and what to track each quarter on the KOSDAQ.
Kots Technology (448710) 2026 stock outlook: combat-system consoles, ruggedized military displays, and tactical communications built for Korea's defense-localization push and export cycle, plus the small-cap liquidity and order-lumpiness risks a foreign investor needs to price in.
Lotte Innovate (formerly Lotte Data Communication, KRX 286940) stock outlook 2026: captive IT revenue from Lotte Group, the AI/cloud pivot, the EVSIS EV-charging bet, competition versus Samsung SDS and LG CNS, and KRW FX plus tax mechanics foreign investors face buying a Korean-listed stock directly.
A qualitative 2026 outlook on Monami (005360), Korea's iconic pen maker. We weigh the structural decline of handwriting demand against the durable brand equity of the Monami 153, the pivot into premium goods, art materials and cosmetics, and the low-liquidity, high-volatility reality of a small-cap consumer stock.
Woori Technology (032820) stock outlook 2026: a qualitative look at how this KOSDAQ nuclear instrumentation and control (MMIS) specialist benefits from Korea's nuclear buildout, why its order-driven revenue swings hard, and what US investors should watch before buying a small-cap Korean nuclear supplier.
Vitzrotech (042370) stock outlook 2026 for global investors. A KOSDAQ-listed South Korean maker of switchgear and distribution panels with defense (shell-body machining) and KSTAR/ITER fusion-facility exposure — here's how to separate the fusion-theme rallies from actual earnings.
Shinil Electronics (002700) stock outlook 2026: a deep qualitative look at Korea's number one household fan brand, its push into dehumidifiers and air circulators, heatwave seasonality, thin margins under Chinese OEM pricing pressure, and the brand relaunch that could decide its next decade.
Multicampus (067280) stock outlook 2026: a qualitative deep dive into the Samsung-affiliated corporate e-learning and OPIc language-assessment platform, its captive revenue dependency, cyclical B2B training budgets, and the AI reskilling opportunity.
ITM Semiconductor (084850) stock outlook for 2026 covering its battery protection circuit and PMIC packaging business, smartphone-cycle dependence, wearable and power-tool diversification, peer comparison, and a practical guide for US investors on access, tax, and FX exposure.
HFR (230240) stock outlook 2026: an independent look at this Korean telecom equipment maker's mobile fronthaul, broadband access, and optical transport business, its dependence on carrier capex cycles, the private 5G opportunity, and competitive pressure from Ericsson, Nokia, and Samsung.
WINS (136540) stock outlook 2026: the Korean intrusion prevention systems leader spun off from Nowcom, its DDoS defense and managed security recurring revenue, 5G/100G IPS ties to LG Uplus and Intel, Japan export ambitions, and the government-telecom capex risk that international investors need to understand.
NICE Information & Telecommunication (036800) stock outlook 2026: how South Korea's leading offline card-payment VAN operator navigates merchant fee regulation and simple-pay apps like Naver Pay, Kakao Pay and Toss, plus its overseas and value-added service growth levers.
ESTsoft (047560) stock outlook for 2026 covering the ALYac antivirus and EstOffice legacy cash business, the AI Human virtual-human pivot, generative AI monetization progress, small-cap earnings volatility, and how US investors can actually access this KOSDAQ name.
Toptec (KOSDAQ: 108230) 2026 stock outlook: the battery assembly and module equipment business behind SK On's prismatic cell pilot line, backlog-driven revenue visibility, customer concentration risk, peer comparison against Philoptics, M Plus and Hana Technology, and how global investors access and are taxed on KOSDAQ equipment stocks.
DY (013570, KRX, formerly Dong Yang Mechatronics) 2026 stock outlook. A qualitative deep dive into the holding-company structure behind DY Power's construction-equipment hydraulic cylinders, DY Auto's electrical components, and DY Innovate's solar-mounting business, plus cyclical, currency and holding-discount risk.
Dongkuk Holdings (KRX 001230) 2026 stock analysis for US and global investors: the 2023 spin-off structure, holding company discount, dividend and NAV appeal, steel scrap costs, construction demand cycle, and how to access this Korean steel holding from abroad.
Shinheung Global (KOSPI 004080) 2026 stock outlook. A deep qualitative look at Korea's leading dental-products maker and distributor: unit chairs, dental alloys, needles and crowns, YUHANevertis implants, the Dental Vitamin B2B platform, plus aging-demographics demand, the manufacturing-versus-distribution margin question, buyback-and-cancellation shareholder returns, and how it sits next to Osstem and Dentium.
Daou Data (032190) 2026 stock outlook. A qualitative deep dive into the KOSDAQ-listed top holding company of the Daou-Kiwoom group: its double holding structure over Kiwoom Securities, the persistent NAV discount, its IT distribution and VAN/PG payments business, capital allocation, and governance catalysts.
Pharmicell (005690) stock outlook for 2026. A deep, qualitative look at how mPEG and nucleoside fine-chemical cash flow funds the Cellgram stem-cell pipeline, Korea's first approved autologous stem-cell drug legacy, valuation, and the real risks.